Panspecific antibodies: Novimmune successful in multiple specificities
Antibodies are designed by nature to bind to epitopes on pathogens with high capacity through a unique one binding specificity mechanism. However, with current molecular biology know how, a team of scientists at NovImmune succeeded in rationally inventing an antibody with two specificities within the one antibody binding site paradigm.
According to NovImmune, this novel antibody engineering approach will open future avenues for the design of panspecific therapeutic antibodies, that is, antibodies with a binding site that is rationally designed to have multiple intrinsic binding specificities. The experimental strategy, taken by the NovImmune team, could be potentially expanded to apply wherever there is a therapeutic rationale to simultaneously modulate the activity of two target proteins or epitopes. The benefit of hitting two birds with one stone is to create synergistic therapeutic effects with, for example, redundant biological pathways (chemokines) or two non-overlapping epitopes (aggregating tumor specific antigens).
Topics
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous